Lawsuit disputes claims of popular memory loss supplement

January 9, 2017

A government lawsuit seeks to ban a popular memory loss dietary supplement marketed to seniors, saying there's no scientific evidence to support its claims.

Democratic New York Attorney General Eric Schneiderman (SHNEYE'-dur-muhn) and the Federal Trade Commission filed the Monday against Madison, Wisconsin-based Quincy Bioscience, maker of Prevagen (PREH'-vuh-jehn). The lawsuit seeks a ban on further claims about Prevagen's effectiveness, refunds for consumers and civil penalties.

Prevagen is sold at major retailers and is advertised as being "clinically shown" to support "clearer thinking" and to "improve memory within 90 days."

Schneiderman says Quincy Bioscience based its claims primarily on a study that failed to show a statistically significant improvement in memory.

Quincy Bioscience says it "vehemently disagrees" with the allegations. It calls the lawsuit an "example of government overreach and regulators extinguishing innovation."

Explore further: Herbal supplement maker agrees to quality control measures

Related Stories

NY, Massachusetts, Maryland sue VW over emissions cheating

July 19, 2016

New York state, Massachusetts and Maryland are suing Volkswagen and its affiliates Audi and Porsche over diesel emissions cheating, alleging that the German automakers defrauded customers and violated state environmental ...

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.